Help us improve the Gazette by taking this short survey —

Gazette Website Experience Survey

Notice Title

Consent to the Distribution of New Medicines

Publication Date
20 Nov 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go6657
Title
View PDF
File Type and Size
PDF (26 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines are set out in the Schedule hereto:

Schedule

Product: DBL™ Magnesium Sulfate Concentrated Injection
Active Ingredient: Magnesium sulfate heptahydrate 493mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Siegfried Hameln GmbH, Hameln, Germany
   
Product: Fluzone
Active Ingredients: Influenza virus A (H1N1) haemagglutinin 15mcg
Influenza virus A (H3N2) haemagglutinin 15mcg
Influenza virus B (Victoria) haemagglutinin 15mcg
Dosage Form: Suspension for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Sanofi Pasteur Inc, Pennsylvania, United States of America
   
Product: Gastropanca
Active Ingredient: Pantoprazole sodium sesquihydrate 22.55mg equivalent to pantoprazole 20mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturers: Ipca Laboratories Limited, Silvassa, India
Ipca Laboratories Limited, Pithampur, India
   
Product: Gastropanca
Active Ingredient: Pantoprazole sodium sesquihydrate 45.1mg equivalent to pantoprazole 40mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturers: Ipca Laboratories Limited, Silvassa, India
Ipca Laboratories Limited, Pithampur, India
   
Product: Ipca-Pantoprazole
Active Ingredient: Pantoprazole sodium sesquihydrate 22.55mg equivalent to pantoprazole 20mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturers: Ipca Laboratories Limited, Silvassa, India
Ipca Laboratories Limited, Pithampur, India
   
Product: Ipca-Pantoprazole
Active Ingredient: Pantoprazole sodium sesquihydrate 45.1mg equivalent to pantoprazole 40mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturers: Ipca Laboratories Limited, Silvassa, India
Ipca Laboratories Limited, Pithampur, India
   
Product: Levetiracetam Lupin
Active Ingredient: Levetiracetam 100mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Lupin NZ Limited
Manufacturers: Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal
Medinfar Manufacturing S.A., Sebal, Portugal
   
Product: Pregabalin
Active Ingredient: Pregabalin 25mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India
   
Product: Pregabalin
Active Ingredient: Pregabalin 50mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India
   
Product: Pregabalin
Active Ingredient: Pregabalin 75mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India
   
Product: Pregabalin
Active Ingredient: Pregabalin 100mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India
   
Product: Pregabalin
Active Ingredient: Pregabalin 150mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India
   
Product: Pregabalin
Active Ingredient: Pregabalin 200mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India
   
Product: Pregabalin
Active Ingredient: Pregabalin 225mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India
   
Product: Pregabalin
Active Ingredient: Pregabalin 300mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Pune, India


Dated this 18th day of November 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).